Interpreting genetic risk loci from GWAS in the context of key genes and pathways using QIAGEN Ingenuity Pathway Analysis

August 16, 2023
Genome-wide association studies (GWAS) provide insights into the genetic architecture of disease by identifying susceptibility loci for the disease within a population. If you'd like to identify disease genes and novel biological pathways that underlay the disease pathogenesis to identify novel drug targets, QIAGEN Ingenuity Pathway Analysis (IPA) helps you characterize and validate risk loci within a biological context. In this training, you'll discover how to perform a core analysis for a list of risk loci to study their association with different pathways and regulatory networks.

You'll learn how to:
• Upload and perform a core analysis on a list of GWAS risk loci
• Investigate pathways and regulatory networks to understand biological mechanisms
• Compare enrichment between risk loci analysis to identify biological similarities and difference
• Identify commonalities and differences between risk loci list
• Generate a custom network and contextualize it using public data
• Export high-resolution images and comprehensive tabular results in preferred formats

Related videos


Cross-species comparison and validation for drug discovery and biomarker research using QIAGEN...

128 views September 27, 2023

Some human studies may be unfeasible or unethical, making cross-species...


Somatic variants investigation in critical regulatory pathways

206 views August 25, 2022

This training will focus on using QIAGEN Ingenuity Pathway analysis (IPA) and...


Drug repurposing: from large-scale biological data to therapeutics

531 views July 19, 2022

One of the challenges we are facing today is the high cost and slow pace of...

Discovery and Research

Multi-omic changes in the postnatal mouse heart identified by QIAGEN Ingenuity Pathway Analysis...

411 views May 18, 2020

Multi-omics experiments allow researchers to make important discoveries in...